Prosecution Insights
Last updated: October 27, 2026

Zachary Mark Turpin, USPTO Patent Examiner

Listed by the USPTO as TURPIN, ZACHARY MARK

Tech Center 1600 • Art Units: 1671 1682 1683

This examiner grants 4% of resolved cases

Performance Statistics

4.0%
Allow Rate
-56.0% vs TC avg
92
Total Applications
-5.0%
Interview Lift
1458
Avg Prosecution Days
Based on 25 resolved cases, 2023–2026

Rejection Statute Breakdown

8.4%
§101 Eligibility
17.1%
§102 Novelty
31.1%
§103 Obviousness
28.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18246651 ELECTRIC FIELD AIDED SAMPLE PREPARATION Non-Final OA Agilent Technologies, Inc.
18702323 LOCKED NUCLEIC ACID-MODIFIED MOLECULAR BARCODE, REVERSE PRIMER, PRIMER SET, KIT, METHOD FOR INHIBITING NON-SPECIFIC AMPLIFICATION, AND USE THEREOF Non-Final OA BOE Technology Group Co., Ltd.
18496492 METHODS, COMPOSITIONS, AND SYSTEMS FOR SPATIAL ANALYSIS OF BIOLOGICAL SAMPLES Non-Final OA 10x Genomics, Inc.
18365684 SYSTEMS AND METHODS FOR IMMUNOFLUORESCENCE QUANTIFICATION Final Rejection 10x Genomics, Inc.
17992772 METHOD OF DETECTING TARGET NUCLEIC ACID MOLECULES Final Rejection 10x Genomics, Inc.
17596916 METHOD FOR ASSESSING DIFFERENTIATION STATE OF CELLS AND GELATIN NANOPARTICLES Final Rejection Konica Minolta, Inc.
17416399 RATIOMETRIC FLUORESCENCE CODING METHOD FOR MULTIPLEX NUCLEIC ACID AMPLIFICATION ASSAYS Final Rejection The Johns Hopkins University
17761833 ADAPTER MOLECULE, BIOMOLECULE-ADAPTER MOLECULE COMPLEX COMPOSED OF ADAPTER MOLECULE AND BIOMOLECULE BOUND TOGETHER, BIOMOLECULE ANALYZER AND BIOMOLECULE ANALYSIS METHOD Non-Final OA Hitachi High-Tech Corporation
18782100 LOCKED APTAMER HAIRPIN INTEGRATED HYBRIDIZATION CHAIN REACTION FOR RAPID, INSTRUMENT-FREE BIOMARKER DETECTION Non-Final OA The Texas A&M University System
18173049 INTRA-INDIVIDUAL ANALYSIS FOR PRESENCE OF HEALTH CONDITIONS Final Rejection Flagship Pioneering Innovations VI, LLC
18001425 MOLECULAR MARKERS AND METHODS FOR SAMPLE ANALYSIS VIA MASS SPECTROMETRY Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18038381 Targeted enrichment using nanopore selective sequencing Final Rejection KEYGENE N.V.
17420606 STORING TEMPORAL DATA INTO DNA Non-Final OA The Trustees of Columbia University in the City of New York
17621295 METHOD FOR DIAGNOSING CHRONIC EXPOSURE TO POLLUTION Non-Final OA L’OREAL
18400352 COLORIMETRIC LOOP-MEDIATED ISOTHERMAL AMPLIFICATION SYSTEM Final Rejection Delta Electronics Int’l (Singapore) Pte Ltd
17127159 SEQUENCING CONTROLS Final Rejection GARVAN INSTITUTE OF MEDICAL RESEARCH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Zachary Mark Turpin's allowance rate?

4.0% of resolved applications examined by Zachary Mark Turpin were allowed (25 resolved cases), compared with 39.7% across Art Unit 1671 over the last five years.

Does an interview help with examiner Zachary Mark Turpin?

This examiner's interview lift is -5.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Zachary Mark Turpin take to allow a patent?

Applications allowed by Zachary Mark Turpin took 1,458 days on average from filing to allowance.

Which art unit does examiner Zachary Mark Turpin work in?

Zachary Mark Turpin examines applications in Art Unit 1671 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month